The results obtained in BRCA1 full-length transfected cells suggest that the BRCA1 gene product is a key modulator of drug sensitivity in breast cancer cells in this specifc setting and add novel information as compared to studies performed on breast sporadic tumours. This evidence concerns the gene BRCA1 and breast cancer.